Suchergebnisse - (Person:"Scarsi, Mirko")

PubPharm (5)

1

Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis

enthalten in: Clinical rheumatology | 2016

von Piantoni, S. | Colombo, E. | Tincani, A. | +2

2

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

enthalten in: Rheumatology international | 2015

von Piantoni, S. | Scarsi, M. | Tincani, A. | +1

3

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

enthalten in: Rheumatology international | 2015

von Piantoni, S. | Scarsi, M. | Tincani, A. | +1

4

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

enthalten in: Rheumatology international | 2015

von Piantoni, S. | Scarsi, M. | Tincani, A. | +1

5

Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis

enthalten in: The Journal of rheumatology | 2014

von Scarsi, M. | Paolini, L. | Ricotta, D. | +5

CommentIn: J Rheumatol. 2014 May;41(5):825-8. - PMID 24692519

1
[1]